5-androsten-3beta-ol-17-one.

Pregnenolone sits directly upstream: CYP17A1 converts it through 17-hydroxypregnenolone to this compound. Supplying the upstream steroid feeds the same branch of the pathway from one step earlier. Where the carbon actually goes depends on which downstream enzymes a given tissue expresses, so upstream dosing does not predict the downstream product.

This steroid can be aromatised into oestrogens in peripheral tissue, and DIM shifts oestrogen metabolism toward the 2-hydroxy route through CYP1A1 induction. That is why the two appear together in male-oriented formulations. The effect is on the metabolic split of oestrogen, and it is measured as urinary metabolite ratios rather than as an outcome.

Steroid hormones are cleared largely as glucuronide conjugates, and calcium D-glucarate inhibits beta-glucuronidase, the bacterial enzyme that cuts those conjugates apart in the gut and allows reabsorption. The combination is used with the intention of increasing net steroid clearance. The mechanism is well described; human data on the pairing is not.

Glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase type 2, altering cortisol handling and, at sustained intake, causing potassium loss and higher blood pressure. Stacking it with an adrenal steroid precursor means acting on two points of the same axis at once. This one belongs in the caution column.

Small human studies have reported shifts in sex hormone binding globulin and in the free fraction of circulating androgens with boron supplementation. A change in binding protein alters how much of a hormone is unbound, which is a laboratory measure rather than a demonstrated effect. The studies are small and the finding is not settled.

Several steroidogenic and steroid-metabolising enzymes are zinc-dependent, and marked zinc deficiency lowers androgen production. Correcting a deficiency is not the same as adding zinc on top of adequate status. The relationship applies at the deficient end of the range.

Ashwagandha has been studied for its effects on cortisol measures, and this steroid is itself an adrenal product whose ratio to cortisol is often what gets reported. Combining them means two agents acting on the same axis from different directions. Any joint effect is on hormone measurements, and it has not been tested as a combination.

Both derive from cholesterol and both act through nuclear receptor signalling, and the two are frequently co-measured in ageing research. Shared ancestry in a biosynthetic tree is not a functional interaction. Read this as background context rather than a reason to combine them.

Magnesium has been reported in small studies to reduce binding of testosterone to sex hormone binding globulin, raising the free fraction. That is a change in a laboratory measure with limited replication. It is not a reason to expect a downstream effect.